Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 9/2019

Inhalt (23 Artikel)

Review – Cancer Research

Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application

Han Shuwen, Da Miao, Qi Quan, Wu Wei, Zhang Zhongshan, Zhang Chun, Yang Xi

Original Article – Cancer Research

The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget’s disease

Giorgia Garganese, Frediano Inzani, Giulia Mantovani, Angela Santoro, Michele Valente, Gabriele Babini, Giuliana Petruzzellis, Simona Maria Fragomeni, Stefano Gentileschi, Sonia Bove, Massimo Franchi, Giuseppe Angelico, Anna Fagotti, Giovanni Scambia, Gian Franco Zannoni

Open Access Original Article – Cancer Research

Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells

Julian Böhm, Julienne Kathrin Muenzner, Aylin Caliskan, Benardina Ndreshkjana, Katharina Erlenbach-Wünsch, Susanne Merkel, Roland Croner, Tilman T. Rau, Carol Immanuel Geppert, Arndt Hartmann, Adriana Vial Roehe, Regine Schneider-Stock

Open Access Original Article – Cancer Research

Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis

Selina K. Sutton, Belamy B. Cheung, Hassina Massudi, Owen Tan, Jessica Koach, Chelsea Mayoh, Daniel R. Carter, Glenn M. Marshall

Original Article – Cancer Research

Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer

Sabine Heublein, Michael S. Anglesio, Frederik Marmé, Stefan Kommoss

Original Article – Cancer Research

Possible correlation of sonic hedgehog signaling with epithelial–mesenchymal transition in muscle-invasive bladder cancer progression

Koichi Kitagawa, Katsumi Shigemura, Shian-Ying Sung, Kuan-Chou Chen, Chao-Ching Huang, Yi-Te Chiang, Ming-Che Liu, Tzu-Wen Huang, Fukashi Yamamichi, Toshiro Shirakawa, Masato Fujisawa

Original Article – Cancer Research

REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression

Si Sun, Zhihuang Hu, Shenglin Huang, Xun Ye, Jialei Wang, Jianhua Chang, Xianghua Wu, Qifeng Wang, Lanlin Zhang, Xingjiang Hu, Hui Yu

Original Article – Cancer Research

Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC)

Jenny Hötzel, Nathaniel Melling, Julia Müller, Adam Polonski, Gerrit Wolters-Eisfeld, Jakob R. Izbicki, Karl-F. Karstens, Michael Tachezy

Original Article – Cancer Research

Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors

Sahyun Pak, Wansuk Kim, Yunlim Kim, Cheryn Song, Hanjong Ahn

Original Article – Clinical Oncology

Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma

Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, Shingo Kimura, Fumiko Irisuna, Kyoko Ikeda, Kei Kushitani, Naoto Kishi, Yasuhiro Tsutani, Yukio Takeshima, Morihito Okada

Original Article – Clinical Oncology

Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?

Christian Guido Ruf, Stefan Borck, Petra Anheuser, Cord Matthies, Tim Nestler, Henrik Zecha, Hendrik Isbarn, Klaus-Peter Dieckmann

Original Article – Clinical Oncology

A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patients

Feng Li, Fu-Sheng Yao, Xi-Jun Zhu, Wei-Ying Gu, Xiao-Hua Wang, Bing Chen, Dong-Ping Huang, Jia-Hua Ding, Tian-Qin Wu, Yan Zhu, Qian Zhao, Yu-Mei Tang, Ping Song, Xiao-Gang Zhou, Zhi-Ming An, Xing Guo, Xu-Li Wang, Long Zhong, Xiao-Bao Xie, Yong-Ping Zhai

Original Article – Clinical Oncology

Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study

Francois Ghiringhelli, Julie Vincent, Leila Bengrine, Christophe Borg, Jean Louis Jouve, Romaric Loffroy, Boris Guiu, Julie Blanc, Aurélie Bertaut

Original Article – Clinical Oncology

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

Alessandro Parisi, Alessio Cortellini, Michela Roberto, Olga Venditti, Daniele Santini, Emanuela Dell’Aquila, Marco Stellato, Paolo Marchetti, Mario Alberto Occhipinti, Federica Zoratto, Federica Mazzuca, Nicola Tinari, Michele De Tursi, Laura Iezzi, Clara Natoli, Margherita Ratti, Claudio Pizzo, Michele Ghidini, Giampiero Porzio, Corrado Ficorella, Katia Cannita

Original Article – Clinical Oncology

Impacts of thoracoscopic surgery and high grade histologic subtypes on spread through air spaces in small stage I lung adenocarcinomas

Tieniu Song, Lili Jiang, Zeguo Zhuo, Jun Luo, Guha Alai, Xu Shen, Yidan Lin

Original Article – Clinical Oncology

Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer

Qiang Zhou, Jiangbo Ren, Jinxuan Hou, Gang Wang, Lingao Ju, Yu Xiao, Yan Gong

Original Article – Clinical Oncology

Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database

Yan Li, Song Hu, Jun Xie, Xian Zhang, Yun Zong, Bin Xu, Chong Li

Letter to the Editor

Letter to the editors of the Journal of Cancer Research and Clinical Oncology

H. Matthes, R.-D. Hofheinz, G. Bar-Sela, D. Galun, D. Martin, R. Huber, J. Langhorts, P. F. Matthiessen, F. Schad

Letter to the Editors

Answer to the letter to the editors by Matthes and colleagues regarding our systematic reviews on mistletoe

Jutta Huebner, M. Freuding, C. Keinki, O. Micke, J. Buentzel

Correction

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Francesco Marampon, Flavio Leoni, Andrea Mancini, Ilaria Pietrantoni, Silvia Codenotti, Letizia Ferella, Francesca Megiorni, Giuliana Porro, Elisabetta Galbiati, Pietro Pozzi, Paolo Mascagni, Alfredo Budillon, Roberto Maggio, Vincenzo Tombolini, Alessandro Fanzani, Giovanni Luca Gravina, Claudio Festuccia

Neu im Fachgebiet Onkologie

Informierte Frauen neigen zu späterem Mammografie-Screening

Frauen in ihren 40ern, die über die Vor- und Nachteile des Mammografie-Screenings auf Brustkrebs informiert werden, neigen stärker dazu, den Screeningbeginn nach hinten zu verschieben. Die Mehrheit aber nähme das Angebot an, wie eine US-Studie zeigt.

Endometriose-Subtypen und das Risiko für Ovarialkarzinome

19.07.2024 Ovarialkarzinom Nachrichten

US-Kohortendaten sprechen dafür, dass verschiedene Endometrioseformen unterschiedlich mit dem Risiko für Ovarialkarzinome assoziiert sind. Besonders erhöht ist das Risiko offenbar bei tief infiltrierenden und ovariellen Endometrioseformen.

Die zelluläre Differenzierung wird wiederhergestellt

18.07.2024 Akute myeloische Leukämie Nachrichten

Ivosidenib von Servier ist ein Inhibitor der mutierten Isoform der Isocitrat-Dehydrogenase-1 (IDH1) und wird zur Behandlung von Patientinnen und Patienten mit neu diagnostizierter akuter myeloischer Leukämie (AML) eingesetzt. Die Substanz sorgt für die Wiederherstellung der zellulären Differenzierung.

Weißer Hautkrebs: Ein Update zu Diagnostik und Therapie

18.07.2024 Fortbildungswoche 2024 Kongressbericht

In der aktualisierten Version der S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ gibt es neue Empfehlungen, unter anderem zu erweiterten Optionen bei aktinischer Keratose sowie zur systemischen und chirurgischen Behandlung von Plattenepithelkarzinomen. Ein Überblick.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.